跳至主要内容
临床试验/NL-OMON32491
NL-OMON32491已完成不适用

Pharmacokinetic and pharmacodynamic profile of rapid-acting insulin injected by needle-free jet-injection - Pharmacology of insulin injected with jet-injection

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion criteria for healthy subjects
  • Age 18-50 years
  • Body-mass index 18-28 kg/m2
  • Blood pressure <160/90 mmHg
  • Inclusion criteria for patients with type 1 diabetes
  • Age 18-50 years
  • Body-mass index 18-28 kg/m2
  • Stable glycaemic control with HbA1c 6.5-9.0%
  • Duration of diabetes >1 year
  • Blood pressure <160/90 mmHg

排除标准

  • Exclusion criteria for healthy subjects
  • Inability to provide informed consent
  • Chronic use of medication other than oral contraceptives or thyroid hormone replacement therapy (with stable euthyroidism for at least 3 months)
  • Type 2 diabetes in first-degree relatives
  • History of a major cardiovascular disease event (myocardial infarction, stroke, symptomatic peripheral artery disease, coronary bypass surgery, percutaneous coronary or peripheral artery angioplasty)
  • Pregnancy
  • Exclusion criteria for patients with type 1 diabetes
  • Inability to provide informed consent
  • Chronic use of medication other than insulin, oral contraceptives, thyroid hormone replacement therapy (with stable euthyroidism for at least 3 months), or low-dose angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) treatment
  • Macroalbuminuria, i.e. urinary albumin excretion >200 *g/min in collected urine sample or urinary albumin-to-creatinine ratio >300 mg/g in spot urine sample
  • Symptomatic diabetic neuropathy
  • Proliferative diabetic retinopathy (a history of proliferative retinopathy that was successfully treated with laser coagulopathy is not an exclusion criterion)
  • History of a major cardiovascular disease event (myocardial infarction, stroke, symptomatic peripheral artery disease, coronary bypass surgery, percutaneous coronary or peripheral artery angioplasty)
  • Pregnancy

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验

进行中(未招募)
1 期
Pharmacokinetic and pharmacodynamic profile of rapid-acting insulin injected by needle-free jet-injection - Pharmacology of insulin injected with jet-injectioMedDRA version: 12.0Level: LLTClassification code 10045228Term: Type I diabetes mellitustype 1 diabetes mellitus
EUCTR2009-015398-11-NLRadboud University Nijmegen Medical Centre48
尚未招募
不适用
Study of Ranolazine table In-Vivo Bioequivalence in healthy volunteersIn this study, the disease is not examined. Subject bioequivalence test and reference tablets Ranolase studied..
IRCT20200105046010N13Arena life science24
进行中(未招募)
不适用
A pharmacokinetic and pharmacodynamic study of recombinant human IGF-I (rhIGF-I) in three boys with ALS deficiency, and insulin sensitivity and bone density in patients and heterozygous first-degree relatives. - ALS deficiency: insulin resistance, bone strength & response to rhIGF1ALS (acid label subunit) deficiencyMedDRA version: 12.1Level: LLTClassification code 10056438Term: Growth Hormone Deficiency
EUCTR2010-019296-30-GBniversity Hospital Birmingham NHS Foundation Trust
进行中(未招募)
1 期
Pharmacokinetic and pharmacodynamic evaluation of linezolid administered intravenously in MRSA-positive, morbidly obese patients with pneumonia.
EUCTR2012-005127-33-BEniversity Ghent20
已完成
不适用
Pharmacokinetic and pharmacodynamic modelling of routinely used off label drugs in premature neonates10039911Pijn en sedatiePrematurity10028971
NL-OMON44214Erasmus MC, Universitair Medisch Centrum Rotterdam600
Pharmacokinetic and pharmacodynamic profile of... | 临床试验